1.	Phase III Randomized Study of Beclomethasone Dipropionate and Prednisone in Patients With Grade II Graft-Versus-Host Disease With Gastrointestinal Symptoms Phase: Phase III Type: Supportive care Status: Completed Age: Not specified Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-01149, ENTERON-00-02, NCI-G02-2098, RPCI-DS-01-09, NCT00043147
2.	Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Phase: Phase II, Phase I Type: Supportive care Status: Completed Age: 5 to 75 Sponsor: NCI, Other Protocol IDs: 1500.00, FHCRC-1500.00, RPCI-DS-99-27, NCI-H01-0067, CDR0000068475, NCT00010283
3.	A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: BDP-ENT-01, 1R43CA141968-01, NCT01073384
4.	Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: 2079.00, NCI-2009-01544, FHCRC-2079.00, 6493, NCT00489203
5.	Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract Phase: No phase specified Type: Supportive care Status: Completed Age: 4 to 70 Sponsor: Other Protocol IDs: CDR0000270747, RPCI-DS-01-04, NCT00055666